COVID-19

What people with cancer should know: https://www.cancer.gov/coronavirus

Guidance for cancer researchers: https://www.cancer.gov/coronavirus-researchers

Get the latest public health information from CDC: https://www.cdc.gov/coronavirus/

Get the latest research information from NIH: https://www.covid19.nih.gov

Steffani R. Bailey

I am a Tobacco Treatment and Health Services Researcher.

Steffani R. Bailey, Ph.D.

Oregon Health & Science University

While working on explanatory smoking cessation trials as a postdoctoral fellow, we had to exclude people with certain comorbidities that are quite common among those who smoke. I realized that I wanted my own research career to focus on real-world patients in real-world clinical settings. My goal is to increase access to, and utilization of, effective smoking cessation interventions in health care settings that serve populations disproportionately affected by tobacco use.

Dr. Bailey's work focuses on reducing smoking-related disparities through improved access to, and utilization of, smoking cessation assistance within primary care settings. Specifically, she is interested in understanding how health policies and system-based interventions impact tobacco treatment among patients seen in safety-net settings. Dr. Bailey's interest in tobacco-related research is rooted in her training as a clinical psychologist, as well as having grown up in a small town in southern Oregon where tobacco use remains prevalent.

Dr. Bailey completed a National Institute on Drug Abuse (NIDA) K23 award that used electronic health record (EHR) data to evaluate the impact of the Centers for Medicare & Medicaid Services Meaningful Use of EHRs initiative on smoking status assessment and cessation assistance in safety-net clinics. Her current research project funded by the National Cancer Institute is a pragmatic cluster-randomized trial that examines the reach and effectiveness of a Quitline eReferral system implemented with enhanced academic detailing (intervention condition) compared with implementation without enhanced academic detailing (comparison condition). This study also evaluates the cost-effectiveness of the Quitline eReferral system, both with and without enhanced academic detailing. Dr. Bailey and her colleagues hope to increase the reach of evidence-based cessation treatments through the collaboration between state Quitlines and community health centers that serve large numbers of socioeconomically disadvantaged smokers.


Grant Listing
Project Title Grant Number Program Director Publication(s)
CONNECT: COmpreheNsive traiNing and Engagement in Cessation Treatment
1R01CA255016-01A1
Yvonne Prutzman Publish File


To request edits to this profile, please contact Mark Alexander at alexandm@mail.nih.gov.

Last Updated: 08/17/2021 07:26:11